The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease

Logan Thirugnanasothy (Gateshead, United Kingdom), Logan Thirugnanasothy, Guy MacGowan, Gareth Parry, John Simpson, Paul Corris

Source: International Congress 2016 – Pulmonary hypertension in lung disease
Session: Pulmonary hypertension in lung disease
Session type: Thematic Poster
Number: 2436
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Logan Thirugnanasothy (Gateshead, United Kingdom), Logan Thirugnanasothy, Guy MacGowan, Gareth Parry, John Simpson, Paul Corris. The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease. Eur Respir J 2016; 48: Suppl. 60, 2436

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in COPD
Source: Eur Respir J 2008; 32: 1371-1385
Year: 2008



Pulmonary hypertension in chronic lung disease and hypoxia
Source: Eur Respir J, 53 (1) 1801914; 10.1183/13993003.01914-2018
Year: 2019



Pulmonary hypertension in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 892-905
Year: 2003



Treatment of pulmonary hypertension in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313
Year: 2006

Acute hemodynamic effects of riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015

Acute pulmonary vasoreactivity to beraprost in patients with severe pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 597s
Year: 2002

Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006


Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients
Source: Eur Respir J 2004; 24 : 580-586
Year: 2004



CO2 inhalation attenuates exercise-induced rise of pulmonary artery pressure under acute hypoxia condition
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016


Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics
Source: Eur Respir J 2012; 40: 1401-1409
Year: 2012



Riociguat improves excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Acute vasodilator response in different forms of pre-capillary pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
Source: Eur Respir J, 50 (1) 1701191; 10.1183/13993003.01191-2017
Year: 2017



Hypoxic and hypercapnic respiratory failure
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=1
Year: 2006

Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017